Literature DB >> 23836903

RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability.

Tiffany Yin1, Seong-Jun Cho, Xinbin Chen.   

Abstract

Macrophage inhibitory cytokine-1 (MIC-1), a secreted cytokine, is a direct target of p53 and known to play a role in cell proliferation, apoptosis, cell metastasis, and angiogenesis through autocrine and paracrine signaling. Previous studies have shown that serum levels of MIC-1 closely parallel cancer progression and are being explored as a diagnostic tool. MIC-1 has also shown potential as a therapeutic agent as it has exhibited several anti-carcinogenic activities. Thus, MIC-1 displays two opposing effects: tumor suppression versus promotion. However, it remains unclear whether MIC-1 is regulated by a mechanism other than transcription and how MIC-1 exerts its tumor suppression. In this study, we show that overexpression of RNA-binding protein RNPC1 can increase, whereas knockdown or knock-out of RNPC1 decreases, MIC-1 transcript and protein levels. Additionally, we demonstrate that RNPC1 can bind to MIC-1 mRNA via an AU-rich element within MIC-1 3'-UTR and then enhances MIC-1 mRNA stability. Finally, to explore the functional significance of MIC-1, we showed that knockdown of MIC-1 can decrease RNPC1-induced cell growth suppression. Altogether, we uncover a novel mechanism by which MIC-1 can be regulated through RNPC1 via mRNA stability.

Entities:  

Keywords:  Cell Proliferation; GDF-15; Gene Regulation; MIC-1; RNA-binding Protein; RNPC1; mRNA Decay; p21; p53

Mesh:

Substances:

Year:  2013        PMID: 23836903      PMCID: PMC3745315          DOI: 10.1074/jbc.M113.480186

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.

Authors:  Tibor Kempf; Matthias Eden; Jens Strelau; Marian Naguib; Christian Willenbockel; Jörn Tongers; Jörg Heineke; Daniel Kotlarz; Jian Xu; Jeffery D Molkentin; Hans W Niessen; Helmut Drexler; Kai C Wollert
Journal:  Circ Res       Date:  2006-01-05       Impact factor: 17.367

2.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily.

Authors:  M R Bootcov; A R Bauskin; S M Valenzuela; A G Moore; M Bansal; X Y He; H P Zhang; M Donnellan; S Mahler; K Pryor; B J Walsh; R C Nicholson; W D Fairlie; S B Por; J M Robbins; S N Breit
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

3.  Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta.

Authors:  L N Lawton; M F Bonaldo; P C Jelenc; L Qiu; S A Baumes; R A Marcelino; G M de Jesus; S Wellington; J A Knowles; D Warburton; S Brown; M B Soares
Journal:  Gene       Date:  1997-12-05       Impact factor: 3.688

4.  Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues.

Authors:  M Böttner; C Suter-Crazzolara; A Schober; K Unsicker
Journal:  Cell Tissue Res       Date:  1999-07       Impact factor: 5.249

5.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.

Authors:  John B Welsh; Lisa M Sapinoso; Suzanne G Kern; David A Brown; Tao Liu; Asne R Bauskin; Robyn L Ward; Nicholas J Hawkins; David I Quinn; Pamela J Russell; Robert L Sutherland; Samuel N Breit; Christopher A Moskaluk; Henry F Frierson; Garret M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

6.  The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15.

Authors:  Jong-Sik Kim; Seung Joon Baek; Tina Sali; Thomas E Eling
Journal:  Mol Cancer Ther       Date:  2005-03       Impact factor: 6.261

7.  The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome.

Authors:  Asne R Bauskin; David A Brown; Simon Junankar; Krishan K Rasiah; Sarah Eggleton; Mark Hunter; Tao Liu; Dave Smith; Tamara Kuffner; Greg J Pankhurst; Heiko Johnen; Pamela J Russell; Wade Barret; Phillip D Stricker; John J Grygiel; James G Kench; Susan M Henshall; Robert L Sutherland; Samuel N Breit
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

Review 8.  Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer.

Authors:  Asne R Bauskin; David A Brown; Tamara Kuffner; Heiko Johnen; X Wei Luo; Mark Hunter; Samuel N Breit
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 9.  MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation.

Authors:  W D Fairlie; A G Moore; A R Bauskin; P K Russell; H P Zhang; S N Breit
Journal:  J Leukoc Biol       Date:  1999-01       Impact factor: 4.962

10.  Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation.

Authors:  Hong Yang; Zoran Filipovic; David Brown; Samuel N Breit; Lyubomir T Vassilev
Journal:  Mol Cancer Ther       Date:  2003-10       Impact factor: 6.261

View more
  14 in total

Review 1.  RBM38 in cancer: role and mechanism.

Authors:  Cheng Zou; Ying Wan; Lingjing He; Jin Hai Zheng; Yang Mei; Junfeng Shi; Min Zhang; Zhiqiang Dong; Dingxiao Zhang
Journal:  Cell Mol Life Sci       Date:  2020-07-08       Impact factor: 9.261

Review 2.  Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy.

Authors:  Li-Li Han; Yi Lv; Hui Guo; Zhi-Ping Ruan; Ke-Jun Nan
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors.

Authors:  Jin Zhang; Enshun Xu; Cong Ren; Wensheng Yan; Min Zhang; Mingyi Chen; Robert D Cardiff; Denise M Imai; Erik Wisner; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 4.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 5.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

6.  Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation.

Authors:  Seong-Jun Cho; I-Fang Teng; Min Zhang; Tiffany Yin; Yong-Sam Jung; Jin Zhang; Xinbin Chen
Journal:  Oncotarget       Date:  2015-01-01

7.  PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38.

Authors:  M Zhang; E Xu; J Zhang; X Chen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

8.  Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.

Authors:  Liang Shi; Tian-Song Xia; Xiao-Long Wei; Wenbin Zhou; Jinqiu Xue; Lin Cheng; Peipei Lou; Chunlian Li; Ying Wang; Ji-Fu Wei; Qiang Ding
Journal:  Oncotarget       Date:  2015-05-20

9.  Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expression.

Authors:  Min Tu; Xian Liu; Bei Han; Qianqian Ge; Zhanjun Li; Zipeng Lu; Jishu Wei; Guoxin Song; Baobao Cai; Nan Lv; Kuirong Jiang; Shui Wang; Yi Miao; Wentao Gao
Journal:  Mol Med Rep       Date:  2014-06-10       Impact factor: 2.952

10.  RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.

Authors:  Jin-Qiu Xue; Tian-Song Xia; Xiu-Qing Liang; Wenbin Zhou; Lin Cheng; Liang Shi; Ying Wang; Qiang Ding
Journal:  BMC Cancer       Date:  2014-05-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.